Tevard Biosciences
Boston, US · 29 employees on LinkedIn · 3 known investors
Find your way into Tevard Biosciences
724 people in our graph share verified history with the Tevard Biosciences team — schools, employers, funds. One of them is your warm intro.
Katrin Geyskensunlockedknows Daniel Fischer · together at Arthur D. Little (overlapped)
×3knows the team · via Massachusetts Institute of Technology
×5knows the team · via A.T. Kearney
×2knows the team · via Yale University
knows the team · via Arthur D. Little
Tevard Biosciences develops tRNA-based therapies to provide durable cures for rare genetic diseases caused by nonsense mutations, including cardiomyopathy, muscular dystrophy, and epilepsy. The company uses suppressor tRNA technology to restore full-length protein production across affected organs and tissues.
Founders & leadership
HL
Harvey Lodish
DF
Daniel FischerinCo-Founder, President and CEO, Board MemberDaniel Fischer is co-founder and CEO of Tevard Biosciences, which develops tRNA-based therapies for rare genetic diseases caused by nonsense mutations. He brings experience in innovation, growth management, and focus on genetic disease treatment.
WL
Warren LammertinCo-Founder and Chairman of the BoardWarren Lammert is a co-founder and chairman of Tevard Biosciences, which develops tRNA-based therapies for rare genetic diseases including epilepsy and muscular dystrophy. He holds degrees from Yale University and the London School of Economics, founded Boston-based investment firm Granite Point Capital in 2004, and has spent two decades supporting epilepsy research through board roles at multiple therapeutic companies and co-founding epilepsy.com and the Epilepsy Therapy Project.
HL
Harvey Lodish, Ph.D.Co-Founder, Chair of the SAB, and Board Member
JC
Jeffery Coller, Ph.D.Scientific Co-Founder, Scientific Advisor
Investors · 3
Founder mafia
3 people who came through Tevard Biosciences went on to found or lead other companies.
Competitors · 2
by search overlap
Eli Lilly17 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
Bioworld16 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Tevard Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Tevard Biosciences do?
- Tevard Biosciences develops tRNA-based therapies to provide durable cures for rare genetic diseases caused by nonsense mutations, including cardiomyopathy, muscular dystrophy, and epilepsy. The company uses suppressor tRNA technology to restore full-length protein production across affected organs and tissues.
- Who founded Tevard Biosciences?
- Tevard Biosciences was founded by Harvey Lodish, Daniel Fischer, Warren Lammert, Harvey Lodish, Ph.D., Jeffery Coller, Ph.D..
- Who are Tevard Biosciences's investors?
- Tevard Biosciences's investors include CWRU Technology Ventures, Good Growth Capital, Lauder Partners.
- Where is Tevard Biosciences headquartered?
- Tevard Biosciences is headquartered in Boston, US.